Table 3.
Strain | PCR | MIC (mg/L) | ||||||
---|---|---|---|---|---|---|---|---|
oqxAB | qnrS1 | CIP | LVX | URX | STX | NOR | NAL | |
HUE1 | + | + | 4 (×4)a | 8 (×16) | 4 (×4) | 2 (×16) | 16 | 128 |
TRANSFORMATION OF pHFQ1 AND pHFQ2 | ||||||||
DH5α | − | − | 0.015 | 0.03 | 0.015 | 0.004 | 0.03 | 32 |
DH5α/pHFQ1 | + | − | 0.03 | 0.03 | 0.03 | 0.015 | 0.06 | 64 |
DH5α/pHFQ1(ΔoqxAB::hygr) | − | − | 0.015 | 0.03 | 0.015 | 0.004 | 0.03 | 32 |
DH5α/pHFQ2 | − | + | 0.125 | 0.5 | 0.125 | 0.125 | 0.25 | 128 |
DH5α/pHFQ2(ΔqnrS1::hygr) | − | − | 0.015 | 0.03 | 0.015 | 0.004 | 0.03 | 32 |
DH5α/pHFQ1-pHFQ2 | + | + | 0.25 | 0.5 | 0.125 | 0.25 | 0.25 | >128 |
MUTANTS OBTAINED FROM PLASMID CURING | ||||||||
<Group A> | ||||||||
HUE1A and HUE1A2 | + | + | 2 (×2) | 2 (×4) | 2 (×2) | 1 (×8) | 8 | 64 |
HUE1A-Curoqxqnr | − | − | 0.06 (×2) | 0.125 (×4) | 0.03 (×1) | 0.03 (×4) | 0.5 | 16 |
HUE1A-Reoqx | + | − | 0.125 (×4) | 0.125 (×4) | 0.125 (×2) | 0.06 (×8) | 0.5 | 32 |
HUE1A-Reqnr | − | + | 1 (×2) | 1 (×4) | 1 (×1) | 0.5 (×4) | 8 | 64 |
HUE1A-Reoqxqnr | + | + | 2 (×2) | 2 (×4) | 2 (×2) | 1 (×8) | 8 | 64 |
<Group B> | ||||||||
HUE1B-Curoqx | − | + | 0.25 (×1) | 0.125 (×1) | 0.125 (×1) | 0.03 (×1) | 0.25 | 4 |
HUE1B-Curoqxqnr | − | − | 0.008 (×1) | 0.008 (×1) | 0.008 (×1) | 0.004 (×1) | 0.03 | 1 |
HUE1B-Reoqx | + | − | 0.125 (×8) | 0.06 (×8) | 0.03 (×2) | 0.03 (×8) | 0.25 | 16 |
HUE1B-Reqnr | − | + | 0.125 (×1) | 0.125 (×1) | 0.125 (×1) | 0.03 (×1) | 0.25 | 4 |
HUE1B-Reoqxqnr | + | + | 1 (×4) | 1 (×4) | 0.5 (×2) | 0.25 (×8) | 4 | 32 |
Reduction of MIC by PAβN (-fold),
resistance.